MME and endothelial dysfunction: Sacubitril/valsartan simultaneously suppresses the angiotensin II receptor and neprilysin, and exerts beneficial effects on endothelial dysfunction, cardiac dysfunction, hypertension, HF, ischemic brain damage and cardiovascular ischemia–reperfusion injury in experimental and clinical investigations4,9.